The year 2025 marks the Silver Jubilee anniversary of the ECIR Group — the largest field-trial database for Pituitary Pars Intermedia Dysfunction (PPID) and Equine Metabolic Syndrome (EMS)/Insulin Resistance (IR) in the world, providing the latest research, diagnosis, and treatment information, including dietary recommendations, for horses with these conditions. The approach to help maintain optimum equine health is the Diagnosis, Diet, Trim, and Exercise (DDT/E) Protocol.
Equine Cushing's Disease, also known as PPID, and EMS/IR are distinctly separate conditions. The often overlapping signs can make diagnosis difficult. No longer a death sentence, horses can live long and productive lives if these conditions are managed.
In 2013 the Equine Cushing's and Insulin Resistance Group Inc., an Arizona nonprofit corporation, was approved as a 501(c)3 public charity. Tax-deductible contributions and grants support ongoing research, education, and awareness of Equine Cushing's Disease/PPID and EMS/IR.
The ECIR Group contributes to scientific advancement through peer-reviewed research publications, funding independent research, and recommending best practices to improve the welfare of equines with metabolic disorders.
